首页> 外文期刊>Nature >Innate lymphoid cells regulate CD4~+ T-cell responses to intestinal commensal bacteria
【24h】

Innate lymphoid cells regulate CD4~+ T-cell responses to intestinal commensal bacteria

机译:先天性淋巴细胞调节CD4〜+ T细胞对肠道共生细菌的反应

获取原文
获取原文并翻译 | 示例
       

摘要

最近被定性的“先天淋巴细胞”(ILCs)在功能rn上可被划分成三类。第一类的lLCs产生干扰rn素-γ.第二类的ILCs表达白介素-5、白介素rn-13和双调蛋白:第三类的ILCs 产生白介素rn-17A和白介素-22。ILCs在适应性免疫存在时rn的功能及它们影响适应性免疫细胞反应的潜力rn在很大程度上是不知道的。现在用小鼠所做的rn一项研究显示,第三类的ILCs处理和呈现抗rn原,并通过一个依赖于“MHC-class-II”的机制rn控制CD4~+ T-细胞对小肠共生茵的反应。这一rn发现也许有助于了解与对共生菌的炎性宿主免rn疫反应相关的人类慢性病的病理。%Innate lymphoid cells (ILCs) are a recently characterized family of immune cells that have critical roles in cytokine-mediated regulation of intestinal epithelial cell barrier integrity. Alterations in ILC responses are associated with multiple chronic human diseases, including inflammatory bowel disease, implicating a role for ILCs in disease pathogenesis. Owing to an inability to target ILCs selectively, experimental studies assessing ILC function have predominantly used mice lacking adaptive immune cells'"10. However, in lymphocyte-sufficient hosts ILCs are vastly outnumbered by CD4~+ T cells, which express similar profiles of effector cytokines. Thereforey, the function of ILCs in the presence of adaptive immunity and their potential to influence adaptive immune cell responses remain unknown. To test this, we used genetic or antibody-mediated depletion strategies to target murine ILCs in the presence of an adaptive immune system. We show that loss of retinoic-acid-recqrtor-related orphan receptor-yt-positive (RORγt~+) ILCs was associated with deregulated adaptive immune cell responses against commensal bacteria and low-grade systemic inflammation. Remarkably, ILC-mediated regulation of adaptive immune cells occurred independently of interleukin (IL)-17A, IL-22 or IL-23. Genome-wide transcriptional profiling and functional analyses revealed that RORγt~+ ILCs express major histocompatibility complex class II (MHCII) and can process and present antigen. However, rather than inducing T-cell proliferation, ILCs acted to limit commensal bacteria-specific CD4~+ T-cell responses. Consistent with this, selective deletion of MHCII in murine RORγt~+ ILCs resulted in dysregulated commensal bacteria-dependent CD4~+ T-cell responses that promoted spontaneous intestinal inflammation. These data identify that ILCs maintain intestinal homeostasis through MHCII-dependent interactions with CD4~+ T cells that limit pathological adaptive immune cell responses to commensal bacteria.
机译:最近被定性的“先天淋巴细胞”(ILCs)在功能rn上可被划分成三类。第一类的lLCs产生干扰rn素-γ.第二类的ILCs表达白介素-5、白介素rn-13和双调蛋白:第三类的ILCs 产生白介素rn-17A和白介素-22。ILCs在适应性免疫存在时rn的功能及它们影响适应性免疫细胞反应的潜力rn在很大程度上是不知道的。现在用小鼠所做的rn一项研究显示,第三类的ILCs处理和呈现抗rn原,并通过一个依赖于“MHC-class-II”的机制rn控制CD4~+ T-细胞对小肠共生茵的反应。这一rn发现也许有助于了解与对共生菌的炎性宿主免rn疫反应相关的人类慢性病的病理。%Innate lymphoid cells (ILCs) are a recently characterized family of immune cells that have critical roles in cytokine-mediated regulation of intestinal epithelial cell barrier integrity. Alterations in ILC responses are associated with multiple chronic human diseases, including inflammatory bowel disease, implicating a role for ILCs in disease pathogenesis. Owing to an inability to target ILCs selectively, experimental studies assessing ILC function have predominantly used mice lacking adaptive immune cells'"10. However, in lymphocyte-sufficient hosts ILCs are vastly outnumbered by CD4~+ T cells, which express similar profiles of effector cytokines. Thereforey, the function of ILCs in the presence of adaptive immunity and their potential to influence adaptive immune cell responses remain unknown. To test this, we used genetic or antibody-mediated depletion strategies to target murine ILCs in the presence of an adaptive immune system. We show that loss of retinoic-acid-recqrtor-related orphan receptor-yt-positive (RORγt~+) ILCs was associated with deregulated adaptive immune cell responses against commensal bacteria and low-grade systemic inflammation. Remarkably, ILC-mediated regulation of adaptive immune cells occurred independently of interleukin (IL)-17A, IL-22 or IL-23. Genome-wide transcriptional profiling and functional analyses revealed that RORγt~+ ILCs express major histocompatibility complex class II (MHCII) and can process and present antigen. However, rather than inducing T-cell proliferation, ILCs acted to limit commensal bacteria-specific CD4~+ T-cell responses. Consistent with this, selective deletion of MHCII in murine RORγt~+ ILCs resulted in dysregulated commensal bacteria-dependent CD4~+ T-cell responses that promoted spontaneous intestinal inflammation. These data identify that ILCs maintain intestinal homeostasis through MHCII-dependent interactions with CD4~+ T cells that limit pathological adaptive immune cell responses to commensal bacteria.

著录项

  • 来源
    《Nature》 |2013年第7452期|113-117a4|共6页
  • 作者单位

    Division of Gastroenterology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA,Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA;

    Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA,Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104,USA;

    Division of Gastroenterology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA,Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA,Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104,USA;

    ImmunoDynamics Group, Programs in Computational Biology and Immunology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA;

    Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104,USA;

    Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104,USA;

    Department of Pathology and Laboratory Medicine, and Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA;

    Inflammation and Immunology Research Unit,Biotherapeutics Research and Development, Pfizer Worldwide R&D, Cambridge, Massachusetts 02140, USA;

    Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA,Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104,USA;

    Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA,Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104,USA;

    Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA,Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104,USA;

    Cancer Immunology, Inflammation & Tolerance Program, Georgia Health Sciences University Cancer Center, Augusta, Georgia 30912, USA;

    Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104,USA;

    Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA;

    Lymphoid Tissue Development Unit Institute Pasteur, 75724 Paris, France,Centre National de la Recherche Scientifique, URA1961,75724 Paris, France;

    Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA,Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104,USA,Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA;

    Division of Gastroenterology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA,Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:53:37

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号